← All indications

Obesity, Metabolically Benign

A sub-PHENOTYPE of obese individuals who have a risk for CARDIOVASCULAR DISEASES between that of healthy individuals with normal weight and unhealthy individuals with obesity.

Drugs by status

Phase 1 trials (1)

Other trials (3)

Organizations

Organization Involved with Phase 1 Indications (2)

Organization Involved with Other Experimental Indications (2)